SCHEMBL21476525

SCHEMBL21476525

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5cc6ccccc6o5)cc4)nc(-c4ccc5oc6cc7ccccc7cc6c5c4)n3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 6/20 0.48
PLA2G4A P47712 6/20 0.48
MAOB P27338 3/20 0.48
PLA2G10 O15496 1/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
MAOA P21397 1/20 0.43
ALOX5 P09917 1/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ABCG2 Q9UNQ0 2/20 0.41
TNKS O95271 2/20 0.41
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
CA12 O43570 1/20 0.41
TP53 P04637 1/20 0.41
ABCB1 P08183 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21476411 0.96 PLA2G2A (0.49) PLA2G2APLA2G4AMAOBPLA2G10CA1
SCHEMBL21476393 0.96 PLA2G2A (0.48) PLA2G2APLA2G4AMAOBPLA2G10CA1
SCHEMBL21476770 0.95 PLA2G2A (0.42) PLA2G2APLA2G4AMAOBPLA2G10CA1
SCHEMBL21476498 0.93 PLA2G2A (0.46) PLA2G2APLA2G4AMAOBPLA2G10CA1
SCHEMBL21476369 0.92 PLA2G2A (0.53) PLA2G2APLA2G4AMAOBPLA2G10CA1
SCHEMBL21476614 0.92 MAOB (0.43) PLA2G2APLA2G4AMAOBPLA2G10CA1
SCHEMBL21476271 0.91 MAOB (0.51) PLA2G2APLA2G4AMAOBPLA2G10CA1
SCHEMBL23334957 0.90 PGR (0.45) PLA2G2APLA2G4AMAOBPLA2G10CA1
SCHEMBL21476775 0.90 PLA2G2A (0.44) PLA2G2APLA2G4AMAOBPLA2G10CA1
SCHEMBL25460060 0.89 KMT2A (0.41) PLA2G2APLA2G4ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-05-06 US disclosed
WO-2019198806-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2019-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, MLX, LEF1 PLA2G2A 3064/4885PLA2G4A 4054/4885MAOB 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.